Canadian pharmacy medstore is backed by leading venture firms:
Polaris Venture Partners (www.polarisventures.com) – Founded in 1996, Polaris Venture Partners is a venture capital firm that invests in technology and healthcare companies. With its strong focus on the healthcare sector, Polaris provides valuable industry insights and connections to Ceruleanrx.com, helping the company navigate the complex pharmaceutical landscape.
Venrock (www.venrock.com) – Established in 1969, Venrock is a prominent venture capital firm with a rich history of investing in groundbreaking technology and healthcare companies. By partnering with Canadian Pharmacy, Venrock leverages its deep knowledge in healthcare to drive growth and innovation in the pharmaceutical sector.
Lilly Ventures (www.lillyventures.com) – As the venture capital arm of Eli Lilly and Company, Lilly Ventures has a strong focus on biotechnology, pharmaceutical, and medical technology companies. Their investment in Ceruleanrx.com is a testament to the company’s potential in revolutionizing the pharmaceutical industry.
Lux Capital (www.luxcapital.com) – Lux Capital is a venture capital firm that specializes in investing in science and technology-driven companies, particularly those with a focus on healthcare. With their support, Ceruleanrx.com can continue to develop cutting-edge solutions in the pharmaceutical space.
Bessemer Venture Partners (www.bvp.com) – Founded in 1911, Bessemer Venture Partners is a global venture capital firm with a long history of investing in innovative technology and healthcare companies. By backing Ceruleanrx.com, Bessemer Venture Partners aims to contribute to the growth and development of the pharmaceutical industry through strategic investments.